Share Jeffrey B. Geske, MD / Anjali Tiku Owens, MD - Expert Cardiology Perspectives in HCM: Slowing Disease Progression With Early Diagnosis and Integration of Cardiac Myosin Inhibitors

Copy link

August 29, 2023

Jeffrey B. Geske, MD / Anjali Tiku Owens, MD - Expert Cardiology Perspectives in HCM: Slowing Disease Progression With Early Diagnosis and Integration of Cardiac Myosin Inhibitors

15 minutes

Please visit answersincme.com/PBR860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in managing hypertrophic cardiomyopathy (HCM) discuss best practices for diagnosis and evidence-based strategies using cardiac myosin inhibitors. Upon completion of this activity, participants should be better able to: Identify best practices to optimally diagnose patients with HCM in order to improve patient outcomes; Describe the clinical impact of cardiac myosin inhibitors in managing patients with obstructive HCM; and Outline practical strategies to incorporate cardiac myosin inhibitors into treatment plans for patients with obstructive HCM.

...more